Development and Validation of a Clinical Symptom-based Scoring System for Diagnostic Evaluation of COVID-19 Patients Presenting to Outpatient Department in a Pandemic Situation
- PMID: 33833907
- PMCID: PMC8018900
- DOI: 10.7759/cureus.13681
Development and Validation of a Clinical Symptom-based Scoring System for Diagnostic Evaluation of COVID-19 Patients Presenting to Outpatient Department in a Pandemic Situation
Abstract
Background Preventive strategies in the form of early identification and isolation of patients are the cornerstones in the control of COVID-19 pandemic. We have conducted this study to develop a clinical symptom-based scoring system (CSBSS) for the diagnostic evaluation of COVID-19. Methods In this study, 378 patients presenting to screening outpatient clinic with clinical suspicion of COVID-19 were evaluated for various clinical symptoms. Statistical associations between presenting symptoms and reverse transcription-polymerase chain reaction (RT-PCR) results were analysed to select statistically significant clinical symptoms to design a scoring formula. CSBSS was developed by evaluating clinical symptoms in 70% of the total patients. The cut-off score of the CSBSS was determined from ROC (receiver operating characteristics) curve analysis to obtain a cut-off for optimum sensitivity and specificity. Subsequently, developed CSBSS was validated in the external validation dataset comprising 30% of patients. Results Clinical symptoms like fever >1000F, myalgia, headache, cough and loss of smell had significant association with RT-PCR result. The adjusted odds ratios (95% confidence interval [CI]) for loss of smell, fever >100°F, headache, cough and myalgia were 5.00 (1.78-13.99), 2.05 (1.36-3.07), 1.31 (0.67-2.59), 1.26 (0.70-2.26) and 1.18 (0.50-2.78), respectively. The ROC curve and area under the curve of development and validation datasets were similar. Conclusion The presence of fever >100°F and loss of smell among suspected patients are important clinical predictors for the diagnosis of COVID-19. This newly developed CSBSS is a valid screening tool that can be useful in the diagnostic evaluation of patients with suspected COVID-19. This can be used for the risk stratification of the suspected patients before their RT-PCR results are generated.
Keywords: covid-19; diagnosis; score; screening; validation.
Copyright © 2021, Bhattacharya et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Chest CT in the Emergency Department for Diagnosis of COVID-19 Pneumonia: Dutch Experience.Radiology. 2021 Feb;298(2):E98-E106. doi: 10.1148/radiol.2020203465. Epub 2020 Nov 17. Radiology. 2021. PMID: 33201791 Free PMC article.
-
Clinical decision support tool for diagnosis of COVID-19 in hospitals.PLoS One. 2021 Mar 11;16(3):e0247773. doi: 10.1371/journal.pone.0247773. eCollection 2021. PLoS One. 2021. PMID: 33705435 Free PMC article.
-
False-negative RT-PCR for COVID-19 and a diagnostic risk score: a retrospective cohort study among patients admitted to hospital.BMJ Open. 2021 Feb 9;11(2):e047110. doi: 10.1136/bmjopen-2020-047110. BMJ Open. 2021. PMID: 33563629 Free PMC article.
-
Development and External Validation of a Machine Learning Tool to Rule Out COVID-19 Among Adults in the Emergency Department Using Routine Blood Tests: A Large, Multicenter, Real-World Study.J Med Internet Res. 2020 Dec 2;22(12):e24048. doi: 10.2196/24048. J Med Internet Res. 2020. PMID: 33226957 Free PMC article.
-
Thoracic imaging tests for the diagnosis of COVID-19.Cochrane Database Syst Rev. 2020 Sep 30;9:CD013639. doi: 10.1002/14651858.CD013639.pub2. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2020 Nov 26;11:CD013639. doi: 10.1002/14651858.CD013639.pub3. PMID: 32997361 Updated.
Cited by
-
Simple Symptom-Based Prediction of COVID-19: A Single-Center Study of Outpatient Fever Clinic in Japan.Cureus. 2023 Mar 24;15(3):e36614. doi: 10.7759/cureus.36614. eCollection 2023 Mar. Cureus. 2023. PMID: 37155444 Free PMC article.
-
Risk Factors of Severity and Mortality Among COVID-19 Patients: A Prospective Observational Study From a Tertiary Care Center.Cureus. 2022 Aug 9;14(8):e27814. doi: 10.7759/cureus.27814. eCollection 2022 Aug. Cureus. 2022. PMID: 36106277 Free PMC article.
-
Performance and explainability of feature selection-boosted tree-based classifiers for COVID-19 detection.Heliyon. 2023 Dec 7;10(1):e23219. doi: 10.1016/j.heliyon.2023.e23219. eCollection 2024 Jan 15. Heliyon. 2023. PMID: 38170121 Free PMC article.
-
Genomic surveillance and serological profile of SARS-CoV-2 variants circulating in Macaé and nearby cities, southeastern Brazil.Front Microbiol. 2024 Apr 30;15:1386271. doi: 10.3389/fmicb.2024.1386271. eCollection 2024. Front Microbiol. 2024. PMID: 38746751 Free PMC article.
-
Development of an Item Bank to Assess Patient-Reported Outcomes: Signs, Symptoms, and Impacts of COVID-19.Patient. 2022 Nov;15(6):703-713. doi: 10.1007/s40271-022-00591-x. Epub 2022 Jul 20. Patient. 2022. PMID: 35857266 Free PMC article. Review.
References
-
- Use of hydroxychloroquine for pre-exposure prophylaxis in COVID 19: debate and suggested future course. Agarwal M, Ranjan P, Mittal A, Baitha U. Expert Rev Anti Infect Ther. 2020;7:1–5. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources